Grove Bank & Trust Elanco Animal Health Inc Transaction History
Grove Bank & Trust
- $670 Million
- Q3 2024
A detailed history of Grove Bank & Trust transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Grove Bank & Trust holds 31 shares of ELAN stock, worth $354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31Holding current value
$354% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$952 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$601 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$559 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$266 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$243 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.42B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...